Lv7
3430 积分 2025-03-25 加入
Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease
9天前
已完结
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
9天前
已完结
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
9天前
已完结
Cost-Effectiveness of Earlier Diagnosis of Fibrotic Interstitial Lung Diseases (Fibrotic ILDs) and Earlier Treatment of Its Progressive Form, Progressive Pulmonary Fibrosis (PPF)
10天前
已完结
Effectiveness of biological disease-modifying antirheumatic drugs in progressive pulmonary fibrosis associated with rheumatoid arthritis
10天前
已完结
Defining Progressive Pulmonary Fibrosis: Implications for Clinical Trials, Guidelines, and Patient Care
10天前
已完结
Progressive pulmonary fibrosis: a state-of-the-art review
10天前
已完结
Beyond the Average Treatment Effect: Toward Precision Immunosuppression in Fibrotic Interstitial Lung Disease
10天前
已完结
Prevalence and outcomes of anxiety and depression in fibrotic interstitial lung disease: a registry-based analysis
10天前
已完结
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
10天前
已完结
皖公网安备34019202002308
